Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy
FranceStudy on the Effectiveness of Autologous Stem Cell Transplantation with Cytarabine in Patients with Aggressive Multiple Sclerosis
ItalyStudy on the Effects of TTI-0102 for Patients with MELAS Syndrome
FranceSafety Study of Tradipitant for Patients with Idiopathic or Diabetic Gastroparesis
BelgiumStudy on the Safety and Effectiveness of tolDC for Patients with Relapsing Remitting and Progressive Multiple Sclerosis
BelgiumStudy on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson's Disease
GermanyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BelgiumStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
AustriaStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
FinlandStudy on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome
FranceStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
AustriaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
